SCHEMBL17340217

SCHEMBL17340217

CCC(C)(N)CCC(C)(C)O

nearest known ligand 0.56

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.56
TSHR P16473 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19431737 0.85 TSHR (0.40) ALDH1A1TSHRTDP1
SCHEMBL23839970 0.77 TSHR (0.41) TSHRTDP1
SCHEMBL18784093 0.77 GRM4 (0.35) TSHRTDP1
SCHEMBL37987 0.74 ALDH1A1 (1.00) ALDH1A1TSHR
SCHEMBL21743233 0.74 TSHR (0.32) TSHRTDP1
SCHEMBL22695440 0.74 TSHR (0.32) TSHRTDP1
SCHEMBL20653669 0.74 TSHR (0.32) TSHRTDP1
SCHEMBL351150 0.74 TSHR (0.32) TSHRTDP1
SCHEMBL11474192 0.74
SCHEMBL13494393 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11524973-B2 Metal compounds and methods of fabricating semiconductor devices using the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2022-12-13 US disclosed
US-20210300955-A1 MOLYBDENUM COMPOUND AND METHOD OF MANUFACTURING INTEGRATED CIRCUIT DEVICE USING THE SAME ADEKA CORPORATION (JP) 2021-09-30 US disclosed
US-20200361970-A1 METAL COMPOUNDS AND METHODS OF FABRICATING SEMICONDUCTOR DEVICES USING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-11-19 US disclosed
US-9211340-B2 Means and methods of enhancing delivery to biological systems CAPSUGEL BELGIUM (BE) 2015-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210300955-A1 MOLYBDENUM COMPOUND AND METHOD OF MANUFACTURING INTEGRATED CIRCUIT DEVICE USING THE SAME INTS9, MCM5, INTS6 ALDH1A1 2332/4885TSHR 3142/4885TDP1 2957/4885
US-20200361970-A1 METAL COMPOUNDS AND METHODS OF FABRICATING SEMICONDUCTOR DEVICES USING THE SAME GPX1, SLC39A11, FEM1B ALDH1A1 458/4885TSHR 4770/4885TDP1 1393/4885
US-11524973-B2 Metal compounds and methods of fabricating semiconductor devices using the same GPX1, SLC39A11, FEM1B ALDH1A1 458/4885TSHR 4770/4885TDP1 1393/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.